Dr. Shayla Bergmann
Claim this profileMedical University of South Carolina
Studies Sickle Cell Anemia
Studies Sickle Cell Disease
8 reported clinical trials
9 drugs studied
Area of expertise
1Sickle Cell Anemia
HbSS positive
HbSC positive
HbSβ0-thalassemia positive
2Sickle Cell Disease
HbSS positive
HbSC positive
HbSβ0-thalassemia positive
Affiliated Hospitals
Clinical Trials Shayla Bergmann is currently running
Crizanlizumab
for Pediatric Sickle Cell Disease
The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants ages 6 months to \<18 years with a history of VOC with or without HU/HC, receiving crizanlizumab for 2 years. The efficacy and safety of crizanlizumab was already demonstrated in adults with sickle cell disease. The approach is to extrapolate from the PK/pharmacodynamics (PD) already established in the adult population. The study is designed as a Phase II, multicenter, open-label study.
Recruiting1 award Phase 2
rVWF +/− ADVATE
for Von Willebrand Disease
The main aim of the study is to check effectiveness, side effects, and tolerability of recombinant von Willebrand Factor (rVWF), with or without ADVATE, in the treatment and control of nonsurgical bleeding events in pediatric participants (less than (\<)18 years of age) with severe hereditary von Willebrand disease (VWD). The participants will be treated with rVWF for 12-18 months. Their von Willebrand Disease will be treated by their doctor according to their doctor's usual clinical practice. During the study, participants will be followed up at clinics or over telephone calls.
Recruiting2 awards Phase 3
More about Shayla Bergmann
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Shayla Bergmann has experience with
- Crizanlizumab
- Voxelotor
- SHP655
- Placebo
- VIT-2763
- Placebos
Breakdown of trials Shayla Bergmann has run
Sickle Cell Anemia
Sickle Cell Disease
Priapism
Von Willebrand Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shayla Bergmann specialize in?
Shayla Bergmann focuses on Sickle Cell Anemia and Sickle Cell Disease. In particular, much of their work with Sickle Cell Anemia has involved HbSS positive patients, or patients who are HbSC positive.
Is Shayla Bergmann currently recruiting for clinical trials?
Yes, Shayla Bergmann is currently recruiting for 2 clinical trials in Charleston South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Shayla Bergmann has studied deeply?
Yes, Shayla Bergmann has studied treatments such as Crizanlizumab, Voxelotor, SHP655.
What is the best way to schedule an appointment with Shayla Bergmann?
Apply for one of the trials that Shayla Bergmann is conducting.
What is the office address of Shayla Bergmann?
The office of Shayla Bergmann is located at: Medical University of South Carolina, Charleston, South Carolina 29425 United States. This is the address for their practice at the Medical University of South Carolina.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.